We previously found that the receptor AXL is expressed in 91% of MPNSTs and nearly 95% of neurofibromas (the precursor lesions for MPNSTs), which suggests that AXL dysregulation is an early event in MPNST development [14, 15]. The gene discussed is AXL; the disease is neurofibroma.